CTSH monthly performance report
Check CTSH's monthly returns, drawdown, and seasonality trends — updated every month.
CTSH monthly report
—
Key takeaways
- Cognizant (CTSH) closed November 2026 at $63.01, down 3.23% for the month and −14.34% over the trailing 12 months.
- Year-to-date, CTSH is −24.08%, underperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +8.39% versus its 200-day moving average ($58.13), a bullish technical signal.
- Over the past three years, CTSH has underperformed the S&P 500 by −75.44%, with a relative strength index reading of 56.
- Win rate over the trailing 39 months stands at 51.3% — 20 positive months versus 19 negative months.
Cognizant ended November 2026 at $63.01, posting a monthly return of −3.23%. The S&P 500 returned −0.18% over the same window, leaving relative performance at −3.05%.
The current quarter stands at +9.70% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +8.39% versus the 200-day moving average ($58.13).
Year-to-date, CTSH is −24.08% against SPY +10.62%, a gap of −34.71%. The stock is currently −27.60% below its 52-week high, with maximum 3-year drawdown at −57.30%.
| Period | CTSH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −1.16% | −0.36% | −0.80% |
| 1 Week | −2.64% | +2.59% | −5.24% |
| 1 Month | −3.23% | −0.18% | −3.05% |
| 3 Months | +11.31% | −2.37% | +13.67% |
| 6 Months | +36.83% | +0.83% | +36.00% |
| YTD | −24.08% | +10.62% | −34.71% |
| 12 Months | −14.34% | +12.25% | −26.59% |
| 3 Years | −4.07% | +71.37% | −75.44% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | +42.91% |
| #2 | Aug 2026 | +16.68% |
| #3 | Oct 2026 | +13.35% |
| #4 | Jul 2024 | +11.29% |
| #5 | May 2025 | +10.09% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jun 2026 | −30.54% |
| #2 | Feb 2026 | −21.48% |
| #3 | Apr 2026 | −13.77% |
| #4 | Sep 2026 | −11.06% |
| #5 | Apr 2024 | −10.38% |
| Quarter | Return |
|---|---|
| Q3 2025 | −14.05% |
| Q4 2025 | +23.75% |
| Q1 2026 | −26.08% |
| Q2 2026 | −36.87% |
| Q3 2026 | +48.31% |
| Q4 2026 (QTD) | +9.70% |
| Year | Return |
|---|---|
| 2023 | +32.07% |
| 2024 | +1.81% |
| 2025 | +7.93% |
| 2026 | −24.08% |
| Metric | Value |
|---|---|
| 52-Week High | $87.03 (2026-01-14) |
| 52-Week Low | $37.08 (2026-06-30) |
| Current Price | $63.01 |
| 200-Day Moving Average | $58.13 |
| Price vs 200DMA | +8.39% |
| 3-Year Maximum Drawdown | −57.30% (2026-06-30) |
| Current Drawdown from 52W High | −27.60% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 56 |
| 3-Year Excess Return vs S&P 500 | −75.44% |
| RS Peak | 109.6 (Jan 2024) |
| RS Trough | 34.8 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CTSH's return for this report period?
CTSH returned −3.23% in the latest monthly window ending 2026-11-13.
Has CTSH outperformed SPY year to date?
YTD CTSH: −24.08% vs SPY: +10.62%.
What is CTSH's 12-month return?
−14.34% over the trailing 12 months.
Is CTSH above or below its 200-day moving average?
Price is +8.39% versus 200DMA ($58.13).
What is the maximum drawdown in the 3-year window?
−57.30% on 2026-06-30.